To view this email as a web page, click here.

 
Adverse Events with NSAIDs Linger
A new systematic review and meta-analysis shows that while NSAIDs peaks at two weeks, while gastrointestinal and cardiovascular adverse events linger.
Read more
 
NSAIDs: How Safe for High-Risk Patients?
Canadian researchers examine the safety of short-term use in patients with hypertension, heart failure, or chronic kidney disease.
Read more
 
NSAIDs Not Always Interchangeable
Celecoxib is preferred over naproxen for patients with chronic arthritis and cardiothrombotic diseases who are also taking aspirin, researchers report.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.